Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River (CRL) Gains on Price & Volume Growth Amid FX Woe
12:49pm, Thursday, 30'th Nov 2023
At present, Charles River (CRL) is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
Charles River (CRL) Backs the Quest to Cure SPG56 via New Deal
09:01am, Wednesday, 29'th Nov 2023
Charles River (CRL) and GC4K announce a gene therapy manufacturing collaboration.
Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
09:13am, Sunday, 26'th Nov 2023
Charles River Laboratories provides essential products and services to accelerate research and drug development efforts. The company benefits from competitive advantages thanks to the entry barriers,
The 3 Most Undervalued Tech Stocks to Buy Now: November 2023
06:45pm, Friday, 17'th Nov 2023
Looking for undervalued tech stocks to buy now? At first, it might seem challenging as the Nasdaq Composite keeps sprinting toward new highs.
Charles River (CRL) Widens CliniPrime GMP Suite With New Launch
09:46am, Friday, 17'th Nov 2023
Charles River (CRL) brings CliniPrime Cryopreserved Leukopaks for cell therapy development and manufacturing.
Charles River's (CRL) Q3 Earnings Beat, Margins Decline
12:01pm, Wednesday, 08'th Nov 2023
Charles River's (CRL) RMS organic revenue growth is primarily driven by research model services, particularly the Insourcing Solutions business.
Unlocking Q3 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
12:02pm, Monday, 06'th Nov 2023
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Charles River (CRL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for t
Consulting firm Charles River raises dividend to boost yield above the S&P 500's, while profit and revenue miss expectations
08:15am, Thursday, 02'nd Nov 2023
CRA International Inc. CRAI, +0.09%, the consulting firm also known as Charles River Associates, said Thursday that it raised its quarterly dividend, by 16.7%, to 42 cents a share from 36 cents a shar
Charles River (CRL) to Report Q3 Earnings: What's in Store?
10:33am, Wednesday, 01'st Nov 2023
Charles River's (CRL) CRADLE initiative and research models in North America and China are anticipated to have maintained their growth momentum in the third quarter.
Why Charles River (CRL) Could Beat Earnings Estimates Again
01:32pm, Tuesday, 24'th Oct 2023
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain Charles River (CRL) Stock Now
10:31am, Tuesday, 10'th Oct 2023
Investors are optimistic about Charles River (CRL) on robust RMS segment growth and upbeat guidance.
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
12:55pm, Thursday, 05'th Oct 2023
Stocks ended the third quarter on a sour note. The Federal Reserve's aggressive posture against inflation combined with soaring interest rates have investors taking defensive measures.
Charles River (CRL) Launches LVV-based Gene Therapy Platform
12:46pm, Monday, 02'nd Oct 2023
Charles River's (CRL) LVV platform provides medicinal developers with an efficient, dependable route to the clinic and the market.
Charles River (CRL) Opens a RightSource Lab in Stevenage
09:46am, Tuesday, 26'th Sep 2023
Charles River's (CRL) new RightSource facility is likely to provide services to the Stevenage advanced therapy biocluster.
Here are the 13 stocks Jim Cramer is watching, including Amazon, Oracle and Nike
09:48am, Friday, 22'nd Sep 2023
Here are some of the tickers on my radar for Friday, Sept. 22, taken directly from my reporter's notebook.
